ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $49,000 | -76.1% | 75,584 | -59.8% | 0.00% | – |
| Q4 2021 | $205,000 | -83.5% | 188,231 | -72.4% | 0.00% | -100.0% |
| Q3 2021 | $1,243,000 | +82.0% | 683,102 | +164.2% | 0.00% | – |
| Q2 2021 | $683,000 | +48.5% | 258,589 | +102.5% | 0.00% | – |
| Q1 2021 | $460,000 | +146.0% | 127,693 | +72.5% | 0.00% | – |
| Q4 2020 | $187,000 | +87.0% | 74,033 | +86.9% | 0.00% | – |
| Q3 2020 | $100,000 | -32.4% | 39,614 | -12.4% | 0.00% | – |
| Q2 2020 | $148,000 | +15.6% | 45,241 | -13.6% | 0.00% | – |
| Q1 2020 | $128,000 | -39.9% | 52,359 | +16.0% | 0.00% | – |
| Q4 2019 | $213,000 | +33.1% | 45,153 | +20.8% | 0.00% | – |
| Q3 2019 | $160,000 | -1.8% | 37,387 | +33.5% | 0.00% | – |
| Q2 2019 | $163,000 | +68.0% | 28,011 | +10.7% | 0.00% | – |
| Q1 2019 | $97,000 | +67.2% | 25,308 | -18.0% | 0.00% | – |
| Q4 2018 | $58,000 | -14.7% | 30,877 | +46.1% | 0.00% | – |
| Q3 2018 | $68,000 | -60.5% | 21,129 | -62.9% | 0.00% | – |
| Q2 2018 | $172,000 | -10.9% | 56,934 | +15.8% | 0.00% | – |
| Q1 2018 | $193,000 | -76.7% | 49,187 | -75.4% | 0.00% | -100.0% |
| Q4 2017 | $827,000 | +57.5% | 199,677 | +133.4% | 0.00% | 0.0% |
| Q3 2017 | $525,000 | -1.5% | 85,569 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $533,000 | +3.7% | 85,676 | +5.8% | 0.00% | 0.0% |
| Q1 2017 | $514,000 | +403.9% | 81,011 | +325.7% | 0.00% | – |
| Q4 2016 | $102,000 | -2.9% | 19,032 | +2.3% | 0.00% | – |
| Q3 2016 | $105,000 | -80.5% | 18,600 | -81.0% | 0.00% | -100.0% |
| Q2 2016 | $538,000 | +214.6% | 97,985 | +325.2% | 0.00% | – |
| Q1 2016 | $171,000 | -2.8% | 23,042 | +8.9% | 0.00% | – |
| Q4 2015 | $176,000 | -18.9% | 21,152 | -12.0% | 0.00% | – |
| Q3 2015 | $217,000 | -15.6% | 24,045 | +12.2% | 0.00% | -100.0% |
| Q2 2015 | $257,000 | -63.4% | 21,431 | -67.2% | 0.00% | 0.0% |
| Q1 2015 | $703,000 | +66.2% | 65,320 | -21.7% | 0.00% | 0.0% |
| Q4 2014 | $423,000 | +93.2% | 83,400 | +0.4% | 0.00% | – |
| Q3 2014 | $219,000 | -37.8% | 83,053 | -4.8% | 0.00% | -100.0% |
| Q2 2014 | $352,000 | -56.7% | 87,220 | -50.9% | 0.00% | -50.0% |
| Q1 2014 | $813,000 | +44.9% | 177,521 | +37.3% | 0.00% | +100.0% |
| Q4 2013 | $561,000 | +87.6% | 129,307 | +70.3% | 0.00% | 0.0% |
| Q3 2013 | $299,000 | +251.8% | 75,951 | +89.1% | 0.00% | – |
| Q2 2013 | $85,000 | – | 40,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |